CeGaT, JSW, and NMI work on novel Alzheimer’s Disease Models

CeGaT, JSW Lifesciences GmbH, Grambach, Austria, and NMI Naturwissenschaftliches und Medizinisches Institut an der Universität Tübingen, Reutlingen, Germany, today announced that they will develop novel models for Alzheimer’s and related diseases based on the mitochondrial cascade hypothesis. Within the three year project, knocking-down of mitochondrial proteins will be used to elucidate the specific involvement of […]

New Retina subpanels

CeGaT introduces three additional Subpanels for Hereditary Eye Diseases: Stargardt disease and macular dystrophies (11 Genes) Cone rod dystrophies (25 Genes) Flecked retina disorders (6 Genes) We are now offering 32 Subpanels: Dementia and ALS (1 Subpanel – 20 Genes) Parkinson Syndrome (1 Subpanel – 16 Genes) Epilepsy (15 Subpanels – 265 Genes) Hereditary Eye […]

Exome Sequencing and Nature Genetics

The group of Dr. Holger Prokisch, Institute of Human Genetics, Helmholtz Zentrum, Munich, Germany, was able to identify a new gene (ACAD9) as cause of complex I deficiency, a severe mitochondrial disorder. The gene was identified through Exome Sequencing performed at CeGaT GmbH. Most interestingly, this study demonstrates how Exome Sequencing can contribute to finding […]

CeGaT offers Customized FISH Assays

Starting today, CeGaT together with Prof. Perner, Director of the Institute of Prostate Cancer Research, University Hospital of Bonn, offers the development of FISH assays for in-situ detection of amplifications, deletions, and translocations for nealy all gene loci, tailored to individual needs. Upon request we perform in-situ hybridisation on your material and the analysis of […]

Article on CeGaT in GenomeWeb / InSequence

Today Monica Heger of GenomeWeb / InSequence published an article on CeGaT and its Diagnostic Panels. Read the article on the GenomeWeb website.